This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Senseonics’s 8K filing here.
Senseonics Company Profile
Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
Recommended Stories
- Five stocks we like better than Senseonics
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Investing in the High PE Growth Stocks
- 3 Hot Stock Trends to Ride Into 2025
